Nasus Pharma NSRX Insider Ownership

NYSE NSRX
$3.37 -0.51 (-12.61%)
As of: Sep 9, 2026 · 3:53 PM EDT

Insider Holdings by Owner

163.54K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
—
share count not reported for this filer set
Shares Held by Insiders
163.54K
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
—
not reported
Direct Holdings
163.54K
Indirect: 0
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
1
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —
Form 4 Holdings

Insiders Holding NSRX

Insiders 1
Shares held 163.54K
Of outstanding —
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Dan Benjamin Teleman Chief Executive Officer 163,541 0 163,541 100.0% 22 Jun, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

3 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
17 Jun, 2026 Dan Benjamin Teleman Chief Executive Officer Acquired P 6,550 $3.10 $20.31K 163,541 Direct
22 Apr, 2026 Dan Benjamin Teleman Chief Executive Officer Acquired P 2,900 $3.76 $10.90K 156,991 Direct
31 Mar, 2026 Dan Benjamin Teleman Chief Executive Officer Acquired P 15,000 $2.04 $30.60K 21,246 Direct